ASSOCIATION BETWEEN EPICARDIAL FAT VOLUME AND CORONARY ARTERY DISEASE ON CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY

Thị Lan Hương Lê, Tuấn Vũ Nguyễn

Main Article Content

Abstract

Background: Epicardial adipose tissue exerts metabolic and pro-inflammatory effects that influence the coronary atherosclerotic process. Coronary computed tomography angiography (CCTA) is a first-line modality for quantifying epicardial fat volume (EFV). Prior studies suggest EFV is an independent prognostic factor for coronary artery disease (CAD) and an imaging biomarker reflecting atherosclerotic burden. Objectives: The aim of study was to examine the association between EFV and CAD, and the correlation between EFV and stenosis severity based on the CAD-RADS classification. To assess the diagnostic performance of EFV—area under the curve (AUC), sensitivity, and specificity—in predicting CAD. Methods: We included all consecutive patients aged ≥18 years with suspected CAD who underwent CCTA at Tam Anh General Hospital, Ho Chi Minh City, from October 2024 to September 2025. EFV was measured semi-automatically using Syngo.via software (Siemens Healthcare) with an attenuation threshold from −190 to −30 Hounsfield units; volumes were summed from the pulmonary artery bifurcation to the cardiac apex. CAD was defined as ≥50% diameter stenosis of at least one epicardial coronary artery on CCTA. Results: Among 213 patients (118 men, 55.4%; mean age 64.7 ± 11.3 years), EFV was higher in those with CAD than in those without (122.8 ± 40.8 vs. 85.6 ± 22.1 cm³; p < 0.001). EFV correlated positively and moderately with stenosis severity by CAD-RADS (Spearman’s r = 0.523, p < 0.001). EFV showed good discrimination for CAD with an AUC of 0.79 at a cut-off of 100 cm³, yielding 70.0% sensitivity and 81.2% specificity. Conclusions: EFV is associated with stenosis severity according to CAD-RADS and serves as a predictive imaging marker for coronary artery disease.

Article Details

References

1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. International journal of cardiology. 2013;168(2):934-945.
2. Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis. 2011;214(1):3-10.
3. Gaborit B, Sengenes C, Ancel P, Jacquier A, Dutour-Meyer A. Role of epicardial adipose tissue in health and disease: a matter of fat? Comprehensive physiology. 2017;7(3):317 p.
4. Goeller M, Achenbach S, Cadet S, et al. Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease. JAMA cardiology. 2018;3(9):858-863.
5. Monti CB, Codari M, De Cecco CN, Secchi F, Sardanelli F, Stillman AE. Novel imaging biomarkers: epicardial adipose tissue evaluation. The British journal of radiology. 2020;93(1113)
6. Yu W, Liu B, Zhang F, et al. Association of epicardial fat volume with increased risk of obstructive coronary artery disease in Chinese patients with suspected coronary artery disease. Journal of the American Heart Association. 2021;10(6):e018080.
7. Minh TPV. Độ dày lớp mỡ thượng tâm mạc trên siêu âm tim qua thành ngực ở bệnh nhân bệnh đông mạch vành. Luận văn Thạc sỹ Y học - Đại học Y dược TP Hồ Chí Minh. 2022;
8. Khurana R, Yadav A, Buxi T, Sawhney J, Rawat KS, Ghuman SS. Correlation of epicardial fat quantification with severity of coronary artery disease: A study in Indian population. Indian heart journal. 2018;70:S140-S145.
9. Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. European heart journal. 2024;45(38):4063-4098.
10. Zhou J, Chen Y, Zhang Y, et al. Epicardial fat volume improves the prediction of obstructive coronary artery disease above traditional risk factors and coronary calcium score: development and validation of new pretest probability models in chinese populations. Circulation: Cardiovascular Imaging. 2019;12(1):e008002.